These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 31327094)
1. 5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer's disease modifying agents. Yazdani M; Edraki N; Badri R; Khoshneviszadeh M; Iraji A; Firuzi O Mol Divers; 2020 Aug; 24(3):641-654. PubMed ID: 31327094 [TBL] [Abstract][Full Text] [Related]
2. New Benzamides as Multi-Targeted Compounds: A Study on Synthesis, AChE and BACE1 Inhibitory Activity and Molecular Docking. Drozdowska D; Maliszewski D; Wróbel A; Ratkiewicz A; Sienkiewicz M Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834347 [TBL] [Abstract][Full Text] [Related]
3. Baicalein as a Potential Inhibitor against BACE1 and AChE: Mechanistic Comprehension through In Vitro and Computational Approaches. Han J; Ji Y; Youn K; Lim G; Lee J; Kim DH; Jun M Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703329 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, biological activities, and evaluation of molecular docking-dynamics studies of new thiosemicarbazones that may be effective against Alzheimer's disease. Conger N; Osmaniye D; Sağlık BN; Levent S; Ozkay Y; Kaplancıklı ZA J Mol Recognit; 2023 Dec; 36(12):e3059. PubMed ID: 37723924 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory evaluation of sulfonamide chalcones on β-secretase and acylcholinesterase. Kang JE; Cho JK; Curtis-Long MJ; Ryu HW; Kim JH; Kim HJ; Yuk HJ; Kim DW; Park KH Molecules; 2012 Dec; 18(1):140-53. PubMed ID: 23344193 [TBL] [Abstract][Full Text] [Related]
8. Pyrimidine-morpholine hybrids as potent druggable therapeutics for Alzheimer's disease: Synthesis, biochemical and in silico analyses. Zaib S; Younas MT; Khan I; Ali HS; McAdam CJ; White JM; Jaber F; Awwad NS; Ibrahium HA Bioorg Chem; 2023 Dec; 141():106868. PubMed ID: 37738768 [TBL] [Abstract][Full Text] [Related]
9. New sulfonamide derivatives based on 1,2,3-triazoles: synthesis, Şahin İ; Çeşme M; Güngör Ö; Özgeriş FB; Köse M; Tümer F J Biomol Struct Dyn; 2024 Jun; 42(9):4782-4799. PubMed ID: 37317998 [TBL] [Abstract][Full Text] [Related]
10. Cholinesterase Inhibitory and Anti-Inflammatory Activity of the Naphtho- and Thienobenzo-Triazole Photoproducts: Experimental and Computational Study. Mlakić M; Faraho I; Odak I; Kovačević B; Raspudić A; Šagud I; Bosnar M; Škorić I; Barić D Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834138 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of a New Class of Spirooxindole-Benzo[ Barakat A; Alshahrani S; Al-Majid AM; Ali M; Altowyan MS; Islam MS; Alamary AS; Ashraf S; Ul-Haq Z Molecules; 2020 Oct; 25(20):. PubMed ID: 33066293 [TBL] [Abstract][Full Text] [Related]
12. In Vitro and In Silico Kinetic Studies of Patented 1,7-diEthyl and 1,7-diMethyl Aminoalkanol Derivatives as New Inhibitors of Acetylcholinesterase. Grodner B; Napiórkowska M; Pisklak DM Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008697 [TBL] [Abstract][Full Text] [Related]
13. Factors Influencing the Potency of Alzheimer Inhibitors: Computational and Docking Studies. Atlam F; Awad M; Salama R Am J Alzheimers Dis Other Demen; 2018 May; 33(3):166-175. PubMed ID: 29301410 [TBL] [Abstract][Full Text] [Related]
14. New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation. Ayoup MS; Ghanem M; Abdel-Hamid H; Abu-Serie MM; Masoud A; Ghareeb DA; Hawsawi MB; Sonousi A; Kassab AE BMC Chem; 2024 Jul; 18(1):130. PubMed ID: 39003489 [TBL] [Abstract][Full Text] [Related]
15. Molecular interaction of human acetylcholinesterase with Pitchai A; Rajaretinam RK; Mani R; Nagarajan N Heliyon; 2020 Sep; 6(9):e04930. PubMed ID: 32995619 [TBL] [Abstract][Full Text] [Related]
16. Exploring theophylline-1,2,4-triazole tethered Saeed S; Shahzadi I; Zahoor AF; Al-Mutairi AA; Kamal S; Faisal S; Irfan A; Al-Hussain SA; Muhammed MT; Zaki MEA Front Chem; 2024; 12():1372378. PubMed ID: 38645776 [TBL] [Abstract][Full Text] [Related]
17. Exploring bi-carbazole-linked triazoles as inhibitors of prolyl endo peptidase via integrated in vitro and in silico study. Ullah S; Mansoor F; Khan SA; Jabeen U; Almars AI; Almohaimeed HM; Basri AM; Alshabrmi FM Sci Rep; 2024 Apr; 14(1):7675. PubMed ID: 38561470 [TBL] [Abstract][Full Text] [Related]
18. Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine-Triazole Adducts. Tummatorn J; Meewan I; Khunnawutmanotham N; Chimnoi N; Suwanwong N; Rodphon W; Thongsornkleeb C; Yang J; Ruchirawat S ChemMedChem; 2024 Jul; ():e202400447. PubMed ID: 39083643 [TBL] [Abstract][Full Text] [Related]
19. Rational design of novel diaryl ether-linked benzimidazole derivatives as potent and selective BACE1 inhibitors. Quang De T; Nguyen CQ; Le Dang Q; Nguyen Thi NY; Trong Tuan N; Hoon Suh D; Chu J; Bepary S; Lee GH; Kang NS; Cho H; Park WK; Lim HJ Biochem Biophys Res Commun; 2024 Feb; 698():149538. PubMed ID: 38271836 [TBL] [Abstract][Full Text] [Related]
20. Chemoinformatics Study of Benzodiazepine-1, 2, 3-triazole Derivatives Targeting Butyrylcholinesterase. El Allouche Y; Alaqarbeh M; El Aissouq A; El Rhabori S; Ech-Chahdi Y; Bouachrine M; Zaitan H; Khalil F J Fluoresc; 2024 Jun; ():. PubMed ID: 38884828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]